Katherine E. Cameron

ORCID: 0000-0002-0859-0741
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Reproductive Biology and Fertility
  • Assisted Reproductive Technology and Twin Pregnancy
  • Ovarian function and disorders
  • Ovarian cancer diagnosis and treatment
  • Cancer Risks and Factors
  • Endometriosis Research and Treatment
  • Uterine Myomas and Treatments
  • Pregnancy and preeclampsia studies
  • Cancer survivorship and care
  • Prenatal Screening and Diagnostics
  • Reproductive Health and Technologies
  • Muscle and Compartmental Disorders
  • Monoclonal and Polyclonal Antibodies Research
  • Glycosylation and Glycoproteins Research
  • Synthesis and Biological Evaluation
  • Ectopic Pregnancy Diagnosis and Management
  • Thermoregulation and physiological responses
  • Reproductive Health and Contraception
  • Cancer-related cognitive impairment studies
  • Male Breast Health Studies
  • Family Support in Illness
  • Renal cell carcinoma treatment
  • Gestational Trophoblastic Disease Studies
  • Hemoglobinopathies and Related Disorders
  • Cardiovascular Issues in Pregnancy

Johns Hopkins Medicine
2020-2024

University of Pennsylvania
2015-2024

Johns Hopkins Hospital
2024

Johns Hopkins University
2020-2024

Hospital of the University of Pennsylvania
2018-2020

Scripps Clinic
1990-2007

Scripps Health
2007

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTSelective cleavage of trityl protecting groups catalyzed by an antibodyBrent L. Iverson, Katherine E. Cameron, Guiti K. Jahangiri, and Dahna S. PasternakCite this: J. Am. Chem. Soc. 1990, 112, 13, 5320–5323Publication Date (Print):June 1, 1990Publication History Published online1 May 2002Published inissue 1 June 1990https://pubs.acs.org/doi/10.1021/ja00169a044https://doi.org/10.1021/ja00169a044research-articleACS PublicationsRequest reuse...

10.1021/ja00169a044 article EN Journal of the American Chemical Society 1990-06-01

Recent studies have examined level and rate of change anti-Müllerian hormone (AMH) for predicting time to menopause. Limited prospective, longitudinal data exists evaluating measures ovarian reserve (MOR) in cancer survivors.Determine the MOR survivors (15 39 years) compared with similar-aged controls late reproductive-aged (40 50 years).Prospective cohort.Quaternary university hospital.Survivors at least 1 year from therapy completion, controls, controls.Annual visits early follicular-phase...

10.1210/jc.2018-02257 article EN The Journal of Clinical Endocrinology & Metabolism 2018-12-18

<b><i>Purpose:</i></b> The aim of this study was to evaluate the prevalence menopausal symptoms in young cancer survivors immediately following completion chemotherapy. <b><i>Methods:</i></b> This prospective cohort followed 124 females with a new diagnosis requiring chemotherapy assess menopause before treatment and Symptoms were compared after using McNemar test between patients 133 similar-aged healthy controls Pearson...

10.1159/000485917 article EN Oncology 2018-01-01

What is the impact of presence uterine fibroids on risk developing hypertensive disorders pregnancy (HDP) in a predominantly urban, low-income, Black, and Hispanic population women with ultrasound or clinically diagnosed rich phenotypic data to carefully control for potential confounders?

10.1101/2024.03.05.24303830 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2024-03-07
Coming Soon ...